Altos Labs
Altos Labs, Inc. is an American biotechnology research company. Altos Labs' goal is to develop life extension therapies that can halt or reverse the human aging process. Specialized cell therapies based on induced pluripotent stem cells are to be developed for this purpose. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Altos Labs, United States, covering academic research published from 2020 to 2024. Read More.
Open Access Percentage
78%
Total
Publications
274
Total Open
Publications
213
Total
Citations
6.4K
Open Access
Percentage
78%
Total
Publications
274
Total Open
Publications
213
Total
Citations
6.4K
Breakdown
Publisher Open
9%
Both
49%
Other Platform Open
9%
Closed
33%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 68%
74
Hybrid 23%
25
No Guarantees 9%
10
Other Platform Open
Domain 94%
136
Institution 23%
33
Preprint 1%
2
Public 1%
2
Other Internet 1%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 136 |
VU Research Portal | Institution | 6 |
Universitat Pompeu Fabra - Repositori digital de la UPF | Institution | 5 |
Wageningen University & Research - Wageningen University and Researchcenter Publications | Institution | 2 |
Université de Lausanne - SERVAL | Institution | 2 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 2 |
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca | Institution | 2 |
Queen Mary University of London - Queen Mary Research Online | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 2 |
King's College London - Research Portal | Institution | 2 |